Richard McNally
1 appearance in the program
Sessions & presentations
Biopharmaceutical Section P.M. Roundtable Discussion (Added Fee)
Discussion Leader
Presentation: WL06: Project Optimus, Dose Optimization, and the New Draft FDA Guidance
Roundtables – Lunch · Wed, Aug 9 , 12:30 PM